Compare Hasnur Internasional Shipping Tbk. (HAIS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hasnur Internasional Shipping Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Hasnur Internasional Shipping Tbk. trades at Rp184 (market cap 493.74B, 660.5K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Hasnur Internasional Shipping Tbk. is far larger — about 4.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| HAIS | SCPI | |
|---|---|---|
Market Cap | 493.74B | 104.4B |
Volume | 660.5K | — |
Lot | 6.61K | — |
Turnover | 121.21M | — |
Average Price | 183.51 | — |
Value | 121.21M | — |
Indicative Equilibrium Price | 184 | — |
Indicative Equilibrium Volume | 8 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hasnur Internasional Shipping Tbk.
PT Hasnur Internasional Shipping Tbk (the “Company”) was established in Jakarta based on the Notarial Deed No. 47 of Ira Sudjono, S.H., dated December 14, 2009. The Company commenced its commercial operations in August 2010. The Group is part of Hasnur Group.
Read more on HAIS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
